Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Fort Lauderdale, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
50
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Sunshine Biopharma Inc market cap is $1.84M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sunshine Biopharma Inc 52 week high is $464.00 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sunshine Biopharma Inc 52 week low is $2.23 as of November 22, 2026.
Sunshine Biopharma Inc stock price today is $2.23.
Sunshine Biopharma Inc stock price yesterday was $2.35.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Sunshine Biopharma Inc's P/E ratio is -0.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Sunshine Biopharma Inc P/B ratio is 0.0217.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Sunshine Biopharma Inc 50-day moving average is $8.07.